Advanced search
Publication Cover
mAbs Volume 15, 2023 - Issue 1
Submit an article Journal homepage
2,626
Views
0
CrossRef citations to date
0
Altmetric
Report

Characterization of the high-affinity anti-CTLA-4 monoclonal antibody JS007 for immune checkpoint therapy of cancer

Jiawei Guana Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), China;b Savaid Medical School, University of Chinese Academy of Sciences, Beijing, ChinaView further author information
,
Hongchuan Liuc Department of Antibody Discovery and Engineering, Shanghai Junshi Biosciences Co Ltd, Shanghai, ChinaView further author information
,
Yan Chaia Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), ChinaView further author information
,
Jie Yud Pilot National Laboratory for Marine Science and Technology (Qingdao), Shandong, ChinaView further author information
,
Jian Yaoc Department of Antibody Discovery and Engineering, Shanghai Junshi Biosciences Co Ltd, Shanghai, ChinaView further author information
,
Jing Wangc Department of Antibody Discovery and Engineering, Shanghai Junshi Biosciences Co Ltd, Shanghai, ChinaView further author information
,
Zhiwei Panc Department of Antibody Discovery and Engineering, Shanghai Junshi Biosciences Co Ltd, Shanghai, ChinaView further author information
,
Jing Zhangc Department of Antibody Discovery and Engineering, Shanghai Junshi Biosciences Co Ltd, Shanghai, ChinaView further author information
,
Yuehua Zhouc Department of Antibody Discovery and Engineering, Shanghai Junshi Biosciences Co Ltd, Shanghai, ChinaView further author information
,
Hui Liuc Department of Antibody Discovery and Engineering, Shanghai Junshi Biosciences Co Ltd, Shanghai, ChinaView further author information
,
Sheng Yaoc Department of Antibody Discovery and Engineering, Shanghai Junshi Biosciences Co Ltd, Shanghai, ChinaView further author information
,
Jianxun Qia Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), ChinaView further author information
,
Hui Fengc Department of Antibody Discovery and Engineering, Shanghai Junshi Biosciences Co Ltd, Shanghai, ChinaView further author information
,
George F. Gaoa Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), China;b Savaid Medical School, University of Chinese Academy of Sciences, Beijing, ChinaView further author information
,
Qihui Wanga Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), China;b Savaid Medical School, University of Chinese Academy of Sciences, Beijing, ChinaCorrespondence[email protected]
[email protected]
[email protected]
View further author information
,
Yi Shia Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), China;b Savaid Medical School, University of Chinese Academy of Sciences, Beijing, ChinaView further author information
&
Shuguang Tana Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), China;b Savaid Medical School, University of Chinese Academy of Sciences, Beijing, ChinaORCID Iconhttps://orcid.org/0000-0002-2599-4959View further author information
ORCID Icon show all
Article: 2153409 | Received 03 Aug 2022, Accepted 26 Nov 2022, Published online: 13 Dec 2022

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.